Showing results (1-10 of 586) with videos related to
Sort By:
Pageof 59
Transfusion|May 1, 1979
A factor VIII concentrate of intermediate purity and higher potencyJ K Smith, D R Evans, V Stone, et al.Transfusion|September 1, 1978
Methods of assessing factor VIII content of stored fresh frozen plasma intended for preparation of factor VIII concentratesJ K Smith, T J Snape, M E Haddon, et al.Developments in Biological Standardization|January 1, 1979
Testing for potential thrombogenicity of prothrombin complex concentratesT J SnapeDevelopments in Biological Standardization|January 1, 1987
Quality control in the development of coagulation factor concentratesT J SnapeCurrent Medicinal Chemistry|July 27, 2012
2-Arylindoles: a privileged molecular scaffold with potent, broad-ranging pharmacological activityS Lal, T J SnapeVox Sanguinis|January 1, 1985
A pasteurized antithrombin III concentrate for clinical useJ K Smith, L Winkelman, D R Evans, et al.Vox Sanguinis|January 1, 1980
Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yieldR T Wensley, T J SnapeThrombosis and Haemostasis|June 30, 1986
A pasteurised concentrate of human plasma factor XIII for therapeutic useL Winkelman, G E Sims, M E Haddon, et al.British Journal of Haematology|August 1, 1975
A five year experience of the use of factor IX type DE(I) concentrate for the treatment of Christmas disease of OxfordJ L Lane, C R Rizza, T J SnapeDevelopments in Biological Standardization|January 1, 1979
The assay of prekallikrein activator in human blood productsT J Snape, D Griffith, L Vallet, et al.Pageof 59